November 2, 2022 | New York, NY

EXEEVO, a global enterprise SaaS leader focused on revolutionizing healthcare professional and patient experiences for life sciences organizations announced due to accelerated demand and growth in the Asia Pacific region, they have opened an office and Research and Development center in Huangpu District, Shanghai, China. The dedicated R&D facility will focus on developing product enhancements specific to China’s business requirements.

This expansion will enable Exeevo to provide local pharmaceutical companies with a true omnichannel customer experience solution, tailored specifically for the Chinese market and compliant with all data privacy regulations, including the Personal Information Protection Law (PIPL). Exeevo will provide its Omnipresence Customer Experience solution along with Professional Services sourced out of the local market. This full-fledged entry into the China market builds on recent successes including a partnership with a Top 10 Global Pharmaceutical company.

“Today is the beginning of our next chapter in the Asia Pacific region as we continue to grow our investment and product development teams globally,” said Derek J. Evans, Chief Growth Officer, Exeevo. “We chose Shanghai as it is a center of tech excellence with rich IT talent and a strategic location that enables us to scale our solutions with a focus on fulfilling the specific needs of the China market.  Our investment and expansion in the Chinese marketplace demonstrate that Exeevo’s solutions offer a true Omnichannel experience, meeting the needs of the market today and offering a vision for the future, while also complying with local regulations.”